| Views | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 253 |
| July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 5 | 11 | 6 | 6 | 0 | 2 | 0 |
| Views | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 181 |
